vs

Side-by-side financial comparison of MYRIAD GENETICS INC (MYGN) and PROSPERITY BANCSHARES INC (PB). Click either name above to swap in a different company.

PROSPERITY BANCSHARES INC is the larger business by last-quarter revenue ($367.6M vs $209.8M, roughly 1.8× MYRIAD GENETICS INC). Over the past eight quarters, PROSPERITY BANCSHARES INC's revenue compounded faster (19.2% CAGR vs 1.9%).

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...

MYGN vs PB — Head-to-Head

Bigger by revenue
PB
PB
1.8× larger
PB
$367.6M
$209.8M
MYGN
Faster 2-yr revenue CAGR
PB
PB
Annualised
PB
19.2%
1.9%
MYGN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MYGN
MYGN
PB
PB
Revenue
$209.8M
$367.6M
Net Profit
$116.3M
Gross Margin
70.0%
Operating Margin
-2.7%
Net Margin
31.6%
Revenue YoY
-0.4%
Net Profit YoY
-10.7%
EPS (diluted)
$-0.09
$1.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MYGN
MYGN
PB
PB
Q1 26
$367.6M
Q4 25
$209.8M
$275.0M
Q3 25
$205.7M
$273.4M
Q2 25
$213.1M
$267.7M
Q1 25
$195.9M
$265.4M
Q4 24
$210.6M
$267.8M
Q3 24
$213.3M
$261.7M
Q2 24
$211.5M
$258.8M
Net Profit
MYGN
MYGN
PB
PB
Q1 26
$116.3M
Q4 25
$139.9M
Q3 25
$-27.4M
$137.6M
Q2 25
$-330.5M
$135.2M
Q1 25
$-100.0K
$130.2M
Q4 24
$130.1M
Q3 24
$-22.1M
$127.3M
Q2 24
$-36.7M
$111.6M
Gross Margin
MYGN
MYGN
PB
PB
Q1 26
Q4 25
70.0%
Q3 25
69.9%
Q2 25
71.2%
Q1 25
68.5%
Q4 24
71.7%
Q3 24
70.2%
Q2 24
69.6%
Operating Margin
MYGN
MYGN
PB
PB
Q1 26
Q4 25
-2.7%
65.1%
Q3 25
-11.3%
64.4%
Q2 25
-154.5%
64.3%
Q1 25
-14.8%
62.7%
Q4 24
-18.6%
62.0%
Q3 24
-9.4%
62.1%
Q2 24
-17.3%
55.2%
Net Margin
MYGN
MYGN
PB
PB
Q1 26
31.6%
Q4 25
50.9%
Q3 25
-13.3%
50.3%
Q2 25
-155.1%
50.5%
Q1 25
-0.1%
49.1%
Q4 24
48.6%
Q3 24
-10.4%
48.6%
Q2 24
-17.4%
43.1%
EPS (diluted)
MYGN
MYGN
PB
PB
Q1 26
$1.16
Q4 25
$-0.09
$1.48
Q3 25
$-0.29
$1.45
Q2 25
$-3.57
$1.42
Q1 25
$0.00
$1.37
Q4 24
$-0.47
$1.36
Q3 24
$-0.24
$1.34
Q2 24
$-0.41
$1.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MYGN
MYGN
PB
PB
Cash + ST InvestmentsLiquidity on hand
$149.6M
Total DebtLower is stronger
$119.9M
Stockholders' EquityBook value
$368.0M
$8.2B
Total Assets
$706.6M
$43.6B
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MYGN
MYGN
PB
PB
Q1 26
Q4 25
$149.6M
Q3 25
$145.4M
Q2 25
$74.4M
Q1 25
$91.8M
Q4 24
$102.4M
Q3 24
$99.9M
Q2 24
$97.3M
Total Debt
MYGN
MYGN
PB
PB
Q1 26
Q4 25
$119.9M
Q3 25
$119.5M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
MYGN
MYGN
PB
PB
Q1 26
$8.2B
Q4 25
$368.0M
$7.6B
Q3 25
$372.8M
$7.7B
Q2 25
$388.1M
$7.6B
Q1 25
$704.9M
$7.5B
Q4 24
$701.1M
$7.4B
Q3 24
$731.7M
$7.4B
Q2 24
$740.5M
$7.3B
Total Assets
MYGN
MYGN
PB
PB
Q1 26
$43.6B
Q4 25
$706.6M
$38.5B
Q3 25
$728.1M
$38.3B
Q2 25
$677.3M
$38.4B
Q1 25
$1.0B
$38.8B
Q4 24
$1.0B
$39.6B
Q3 24
$1.1B
$40.1B
Q2 24
$1.1B
$39.8B
Debt / Equity
MYGN
MYGN
PB
PB
Q1 26
Q4 25
0.33×
Q3 25
0.32×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MYGN
MYGN
PB
PB
Operating Cash FlowLast quarter
$10.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MYGN
MYGN
PB
PB
Q1 26
Q4 25
$10.6M
$78.3M
Q3 25
$21.1M
$194.8M
Q2 25
$-13.6M
$98.2M
Q1 25
$-16.3M
$178.2M
Q4 24
$6.6M
$-205.8M
Q3 24
$700.0K
$274.6M
Q2 24
$2.6M
$216.5M
Free Cash Flow
MYGN
MYGN
PB
PB
Q1 26
Q4 25
$68.5M
Q3 25
$185.7M
Q2 25
$91.8M
Q1 25
$171.1M
Q4 24
$-210.7M
Q3 24
$270.2M
Q2 24
$211.8M
FCF Margin
MYGN
MYGN
PB
PB
Q1 26
Q4 25
24.9%
Q3 25
67.9%
Q2 25
34.3%
Q1 25
64.5%
Q4 24
-78.7%
Q3 24
103.3%
Q2 24
81.8%
Capex Intensity
MYGN
MYGN
PB
PB
Q1 26
Q4 25
3.6%
Q3 25
3.3%
Q2 25
2.4%
Q1 25
2.7%
Q4 24
1.8%
Q3 24
1.7%
Q2 24
1.8%
Cash Conversion
MYGN
MYGN
PB
PB
Q1 26
Q4 25
0.56×
Q3 25
1.42×
Q2 25
0.73×
Q1 25
1.37×
Q4 24
-1.58×
Q3 24
2.16×
Q2 24
1.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MYGN
MYGN

Segment breakdown not available.

PB
PB

Net Interest Income$321.1M87%
Noninterest Income$46.5M13%

Related Comparisons